4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9 Purity >98.5% (HPLC) Lenvatinib Mesylate Intermediate Factory

Whakaahuatanga Poto:

Ingoa: 4-Chloro-7-Methoxyquinoline-6-Carboxamide

CAS: 417721-36-9

Maamaa: >98.5% (HPLC)

Te ahua: Paura-White ki te Paura Kowhai Maama

Takawaenga o Lenvatinib Mesylate CAS 857890-39-2

Kounga Teitei, Hanganga Aromoni

E-Mail: alvin@ruifuchem.com


Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Nga Ahuatanga matū:

Ingoa matū 4-Chloro-7-Methoxyquinoline-6-Carboxamide
Nga kupu taurite 4-Chloro-7-Methoxy-6-Quinolinecarboxamide;Lenvatinib poke 12;Lenvatinib poke B;Lenvatinib poke LFS-B
Tau CAS 417721-36-9
Tau CAT RF-PI1971
Tūnga Taonga I roto i te Raarangi, Te Whakaputa Whakanui 50MT / Tau
Tātai rāpoi C11H9ClN2O2
Taumaha rāpoi 236.65
Te Whakarewa >205℃ (tikuri)
Kiato 1.380±0.060 g/cm3
Waitohu Ruifu Chemical

Whakatakotoranga:

Tūemi Whakatakotoranga
Te ahua Paura-White ki te Paura Kowhai Maama
Te Maama / Tikanga Tatauria >98.5% (HPLC)
Ngaronga i te whakamaroke <0.50%
Te toenga i runga i te mura <0.50%
Nga poke katoa <1.50%
Proton NMR Spectrum He rite ki te Hanganga
Paerewa Whakamatau Paerewa hinonga
Whakamahinga Takawaenga o Lenvatinib Mesylate (CAS: 857890-39-2)

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Kaata Drum, kia rite ranei ki te hiahia a te kaihoko

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku

Painga:

1

FAQ:

Taupānga:

Ko te 4-Chloro-7-Methoxyquinoline-6-Carboxamide (CAS: 417721-36-9) te nuinga o te whakamahi hei takawaenga o Lenvatinib Mesylate (CAS: 857890-39-2).I whakawhanakehia e Eisai Inc., ko te lenvatinib mesylate he aukati vascular endothelial growth factor receptor (VEGF) he mahi ki te VEGF subtypes 1, 2, me 3 a i whakaaetia e te FDA i te tau 2015 mo te maimoatanga o te mate pukupuku thyroid rerekee kei te rohe. he auau, he metastatic, he ahu whakamua ranei, kaore i aro ki te maimoatanga iodine radioactive.I te marama o Haratua 2016, i whakaaetia e te FDA te rongoa hei rongoa whakakotahi me te everolimus mo te maimoatanga o te mate pukupuku o te pukupuku renal.Na te mea ko te VEGF (me nga kaiwhakawhiwhi take tipu fibroblast, e mohiotia ana ko FGFRs) e whakaarohia ana ka whai waahi ki nga huarahi tohu tohu cardiovascular, ko te VEGF2R me te aukati FGFR te whakaaro ko nga tikanga kei muri i te paanga tuatahi o te lenvatinib mesylate, ko te whakaheke toto.

Tuhia to korero ki konei ka tukuna mai ki a matou